Benazepril for Dogs: How This ACE Inhibitor Protects...
Learn how benazepril for dogs works as an ACE inhibitor to manage heart failure and kidney disease.
What Is Benazepril and How Does It Work in Dogs?
Benazepril hydrochloride belongs to a class of medications called ACE inhibitors — the same class used in human cardiology since the 1980s. In canine medicine, it has become one of the most commonly prescribed cardiovascular and renal medications, particularly for aging dogs with degenerative valve disease or chronic kidney disease (CKD).
The Renin-Angiotensin-Aldosterone System (RAAS)
To understand benazepril, you need to understand the system it targets. The RAAS is an ancient hormonal cascade that regulates blood pressure, fluid balance, and electrolyte homeostasis across virtually all mammals. Here is how it works:
- Renin release: When the kidneys detect low blood pressure or low sodium, specialized cells (juxtaglomerular cells) release the enzyme renin into the bloodstream.
- Angiotensin I formation: Renin cleaves a liver-produced protein called angiotensinogen into angiotensin I — an inactive decapeptide.
- ACE conversion: Angiotensin-converting enzyme (ACE), primarily located in lung capillary endothelium, strips two amino acids from angiotensin I to produce angiotensin II — one of the most potent vasoconstrictors known.
- Downstream effects: Angiotensin II constricts blood vessels (raising blood pressure), stimulates aldosterone release from the adrenal glands (causing sodium and water retention), and promotes cardiac and renal fibrosis over time.
Benazepril blocks step 3. By inhibiting ACE, it reduces angiotensin II levels, leading to vasodilation, reduced blood pressure, decreased aldosterone secretion, and — critically — slowed remodeling of heart and kidney tissue.
Unlike some ACE inhibitors (such as enalapril), benazepril is a prodrug. It is administered as benazepril hydrochloride and then converted by hepatic esterases into its active metabolite, benazeprilat. This hepatic activation pathway gives benazepril a pharmacokinetic advantage: it is partially eliminated through the bile (hepato-biliary excretion), meaning it places less exclusive burden on the kidneys for clearance compared to enalapril, which is almost entirely renally excreted. This dual-excretion profile is one reason veterinarians often prefer benazepril for dogs with concurrent kidney compromise.
The Evolutionary Basis: Why Dogs Have a RAAS Worth Targeting
The RAAS did not evolve to cause heart failure. It evolved to keep wolves alive during scarcity. In ancestral canids — and indeed across all terrestrial vertebrates — the ability to rapidly conserve sodium, retain water, and maintain blood pressure during dehydration, hemorrhage, or prolonged fasting was a survival advantage. A wolf that could maintain perfusion to its brain and muscles after a failed hunt or a fight-related injury was a wolf that lived to reproduce.
The problem in modern domestic dogs is an evolutionary mismatch. The RAAS was optimized for episodic activation — short bursts during crises, followed by return to baseline. In dogs with chronic conditions like degenerative mitral valve disease (DMVD) or CKD, the RAAS becomes persistently activated. The same system that once saved a wolf from bleeding out now accelerates cardiac fibrosis, glomerular sclerosis, and progressive organ damage. Benazepril essentially acts as a pharmacological brake on this maladaptive chronic activation.
This evolutionary perspective matters because it explains why ACE inhibitors are not a cure — they manage a system that is functioning exactly as evolution designed it, but in a context (chronic disease in aging dogs) that natural selection never had to address. Wild canids rarely lived long enough to develop the degenerative conditions that plague 12-year-old Cavalier King Charles Spaniels or 14-year-old Dachshunds.
Physiological Mechanism: What Happens Inside Your Dog's Body
When your dog takes benazepril, here is the cascade of physiological changes that unfolds over the following hours and weeks:
Within 1-2 Hours of Oral Administration
Benazepril is absorbed from the gastrointestinal tract and undergoes hepatic de-esterification to benazeprilat. Peak plasma concentrations of benazeprilat are typically reached within 2 hours in dogs. The active metabolite binds tightly to ACE molecules, particularly in pulmonary endothelium, with an inhibition rate exceeding 90% at therapeutic doses according to pharmacokinetic studies referenced in the Merck Veterinary Manual.
Hemodynamic Effects (Hours to Days)
- Arterial vasodilation: Reduced angiotensin II means less smooth muscle contraction in arterial walls. Systemic vascular resistance drops, and blood pressure decreases — typically by 5-15 mmHg systolic in normotensive dogs, more in hypertensive patients.
- Venous dilation: Mild venodilation reduces preload (the volume of blood returning to the heart), which decreases the stretch on a failing heart's ventricles.
- Reduced afterload: The heart pumps against lower resistance, meaning each contraction requires less energy. For a dog with a leaky mitral valve, this translates to less regurgitant volume and improved forward cardiac output.
Renal Effects (Days to Weeks)
- Efferent arteriole dilation: Angiotensin II preferentially constricts the efferent (outflow) arteriole of the glomerulus. By blocking this, benazepril reduces intraglomerular pressure — the single most important factor in slowing glomerular damage in CKD.
- Reduced proteinuria: Lower glomerular pressure means less protein leaks through the filtration barrier. Studies in dogs with CKD have shown benazepril can reduce urine protein-to-creatinine ratios (UPC) by 30-50%, which is clinically significant because proteinuria itself is nephrotoxic and is an independent predictor of CKD progression.
- Anti-fibrotic effects: Angiotensin II promotes transforming growth factor-beta (TGF-β) signaling, which drives fibrosis in both cardiac and renal tissue. Long-term ACE inhibition slows this pathological remodeling.
Clinical Uses: When Veterinarians Prescribe Benazepril for Dogs
Benazepril is prescribed for two primary indications in canine medicine, and sometimes for a third:
1. Congestive Heart Failure (CHF) — Secondary to Degenerative Mitral Valve Disease or Dilated Cardiomyopathy
In dogs with CHF, benazepril is typically part of a multi-drug protocol that may include furosemide (a loop diuretic), pimobendan (a positive inotrope and vasodilator), and spironolactone (an aldosterone antagonist). The COVE and BENCH veterinary cardiology studies established that ACE inhibitors improve quality of life and may modestly extend survival in dogs with CHF, though the survival benefit is measured in months rather than years. Benazepril does not replace pimobendan — the QUEST and EPIC studies demonstrated pimobendan's superiority in DMVD — but it serves as an important adjunct.
2. Chronic Kidney Disease (CKD) — Particularly with Proteinuria
The BENRIC study (Benazepril in Renal Insufficiency in Cats) and analogous canine research demonstrated that benazepril reduces proteinuria and may slow CKD progression. For dogs with a UPC above 0.5 (or above 2.0 in confirmed proteinuric nephropathy), benazepril is often the first-line anti-proteinuric agent. It is particularly valuable in breeds predisposed to familial nephropathies, such as Soft-Coated Wheaten Terriers and Bernese Mountain Dogs.
3. Systemic Hypertension (Off-Label)
While amlodipine is the first-line antihypertensive in dogs (and especially in cats), benazepril may be added as a second agent when blood pressure remains uncontrolled, or used as monotherapy in mild hypertension. Its blood-pressure-lowering effect is generally more modest than amlodipine's.
| Dog Weight | Typical Dose | Frequency | Common Tablet Size |
|---|---|---|---|
| 5-10 lb (2.3-4.5 kg) | 1.25-2.5 mg | Once daily (may increase to BID) | 2.5 mg tablet (halved) |
| 11-25 lb (5-11.3 kg) | 2.5-5 mg | Once to twice daily | 5 mg tablet |
| 26-50 lb (11.8-22.7 kg) | 5-10 mg | Once to twice daily | 10 mg tablet |
| 51-100 lb (23.1-45.4 kg) | 10-20 mg | Once to twice daily | 20 mg tablet |
| Over 100 lb (45.4+ kg) | 20-40 mg | Once to twice daily | 20 mg tablets (multiple) |
Standard dosing range: 0.25-0.5 mg/kg orally once daily, which may be titrated to 1.0 mg/kg or divided into twice-daily dosing based on clinical response. Your veterinarian will determine the exact dose based on your dog's condition, kidney function, and blood pressure readings. Never adjust dosage without veterinary guidance.
Side Effects, Monitoring, and What Owners Should Watch For
Benazepril is generally well-tolerated in dogs, but as with any medication affecting the RAAS, certain adverse effects require attention:
| Side Effect | Frequency | What It Looks Like | Action Required |
|---|---|---|---|
| Decreased appetite | Uncommon (5-10%) | Skipping meals, less interest in food | Monitor; mention at next vet visit |
| Gastrointestinal upset | Uncommon (5-8%) | Vomiting, soft stool, occasional diarrhea | Give with food; call vet if persistent >48 hours |
| Hypotension | Rare at standard doses | Lethargy, weakness, wobbliness, collapse | Call vet immediately |
| Elevated creatinine (azotemia) | Uncommon; monitored via bloodwork | Increased thirst/urination, dehydration | Vet will monitor at recheck; may adjust dose |
| Hyperkalemia (elevated potassium) | Rare; risk increases with concurrent spironolactone | Muscle weakness, cardiac arrhythmia | Detected on bloodwork; vet adjusts protocol |
| Acute kidney injury | Very rare; typically with overdose or dehydration | Lethargy, vomiting, decreased urination | Emergency — contact vet immediately |
- Your dog collapses, appears faint, or cannot stand
- Vomiting persists for more than 24 hours after starting benazepril
- Your dog stops eating entirely for more than 48 hours
- You notice a sudden decrease in urination
- Your dog is panting excessively or appears distressed at rest
- You accidentally gave a double dose or your dog consumed another pet's medication
If you suspect an accidental overdose, contact the ASPCA Animal Poison Control Center at (888) 426-4435 (24/7, consultation fee applies) or the Pet Poison Helpline at (855) 764-7661.
Required Monitoring Schedule
After starting benazepril, your veterinarian will typically recommend:
- 7-14 days post-start: Blood chemistry panel (BUN, creatinine, electrolytes — especially potassium) and blood pressure measurement
- Every 3-6 months: Repeat bloodwork, urinalysis (including UPC if managing CKD), and blood pressure
- Any dose change: Recheck bloodwork within 1-2 weeks
- CHF patients: Thoracic radiographs and echocardiogram at intervals determined by your veterinary cardiologist
Expect to spend approximately $150-$300 per recheck visit including bloodwork, with echocardiograms running $400-$700 if performed by a veterinary cardiologist. Annual medication costs for benazepril range from $120-$400 depending on dose and whether you use brand-name Fortekor® or compounded generic benazepril from a FDA-registered compounding pharmacy.
Benazepril vs. Enalapril: How Do They Differ for Dogs?
Both are ACE inhibitors, and both are used in canine cardiology and nephrology. The differences are pharmacokinetic rather than pharmacodynamic:
| Feature | Benazepril (Fortekor®) | Enalapril (Enacard®) |
|---|---|---|
| Drug class | ACE inhibitor (prodrug) | ACE inhibitor (prodrug) |
| Active metabolite | Benazeprilat | Enalaprilat |
| Primary excretion route | Dual: hepato-biliary (~65%) and renal (~35%) | Primarily renal (>90%) |
| Advantage in CKD | Preferred — less dependent on kidney clearance | Usable but requires closer monitoring of renal values |
| Typical canine dose | 0.25-0.5 mg/kg once daily (up to 1.0 mg/kg) | 0.5 mg/kg once to twice daily |
| Half-life in dogs | ~3.5 hours (benazeprilat), but ACE binding is prolonged | ~3-4 hours (enalaprilat) |
| Cost (generic equivalent) | $10-$30/month (5 mg dose) | $8-$20/month (5 mg dose) |
| Palatability | Fortekor® tablets are flavored; generally well-accepted | Unflavored tablets; may need to hide in food |
The dual-excretion pathway is benazepril's main clinical advantage. In a dog with Stage 3 CKD whose glomerular filtration rate (GFR) is significantly reduced, a drug that relies entirely on renal clearance (enalapril) can accumulate to higher-than-intended levels, potentially worsening azotemia. Benazepril's biliary excretion provides an alternative clearance route, making it inherently safer in this population — though monitoring remains essential regardless of which ACE inhibitor is chosen.
Common Misconceptions About Benazepril for Dogs
| Myth | Fact |
|---|---|
| "Benazepril cures heart disease in dogs." | Benazepril manages symptoms and slows progression. It does not repair a degenerative mitral valve or reverse dilated cardiomyopathy. It is a disease-modifying therapy, not a cure. |
| "If my dog seems fine, I can stop the medication." | Feeling better is evidence the medication is working. Stopping ACE inhibitors abruptly can cause rebound RAAS activation and acute decompensation, especially in CHF patients. Never discontinue without veterinary direction. |
| "I can give my dog my own benazepril prescription." | Human benazepril (Lotensin®) contains the same active ingredient, but dosing for dogs differs significantly from human dosing. Tablet sizes, formulations, and monitoring requirements are species-specific. Using human prescriptions risks overdose or underdose. |
| "Benazepril will damage my dog's kidneys." | This is a half-truth that causes dangerous non-compliance. ACE inhibitors can cause a mild, expected increase in creatinine (up to 30% from baseline) due to reduced glomerular filtration pressure — this is actually the mechanism by which they protect kidneys long-term. A rise exceeding 30% warrants veterinary reassessment, but the medication itself is renoprotective at appropriate doses. |
| "Natural supplements work just as well as benazepril." | No supplement has demonstrated equivalent RAAS inhibition or the clinical outcome data supporting ACE inhibitors in canine CHF or CKD. Omega-3 fatty acids (EPA/DHA) are a useful adjunct but do not replace ACE inhibition. Discuss all supplements with your veterinarian. |
Breed Variations and Predispositions Relevant to Benazepril Use
While benazepril's mechanism of action is the same across all breeds, the conditions that prompt its prescription show strong breed clustering:
- Cavalier King Charles Spaniels: Over 50% develop degenerative mitral valve disease by age 5, and prevalence approaches 90% in older dogs. Cavaliers are among the most common recipients of benazepril as part of CHF protocols. The breed's earlier onset of DMVD means many Cavaliers start ACE inhibitors at younger ages (6-8 years) compared to mixed-breed dogs.
- Doberman Pinschers: Dilated cardiomyopathy (DCM) prevalence is estimated at 30-50% in the breed. Dobermans with DCM often receive benazepril alongside pimobendan, and occult (pre-clinical) DCM screening via Holter monitor and echocardiogram is recommended for all Dobermans over age 3.
- Soft-Coated Wheaten Terriers: A hereditary protein-losing nephropathy (PLN) affects a significant portion of the breed. Benazepril is often started early when proteinuria is first detected, sometimes before azotemia develops, to reduce glomerular damage.
- Bernese Mountain Dogs: Familial glomerulonephropathy is documented in this breed, and ACE inhibitors are a cornerstone of management alongside dietary protein modification.
- Bull Terriers: Hereditary nephritis (similar to Alport syndrome in humans) can lead to early-onset CKD where benazepril is indicated.
If you own a breed with known cardiac or renal predispositions, discuss proactive screening with your veterinarian. Early detection — before clinical signs appear — is when ACE inhibitors have the greatest potential to alter disease trajectory.
Drug Interactions and Contraindications
Benazepril does not exist in isolation. Most dogs receiving it are on multi-drug protocols, and interactions matter:
- NSAIDs (carprofen, meloxicam, deracoxib): NSAIDs reduce renal prostaglandin synthesis, which can compromise renal blood flow. Combined with an ACE inhibitor's reduction of angiotensin II-mediated efferent arteriole tone, this creates a "double hit" to glomerular filtration. The combination is not absolutely contraindicated, but requires close monitoring and is generally avoided in dogs with pre-existing CKD.
- Spironolactone: This aldosterone antagonist is frequently prescribed alongside benazepril in CHF. The combination is beneficial but increases hyperkalemia risk. Potassium levels must be checked at each recheck.
- Diuretics (furosemide, hydrochlorothiazide): Diuretics reduce blood volume, which can amplify benazepril's hypotensive effect. Dehydration from over-diuresis combined with ACE inhibition is a recognized cause of acute kidney injury in CHF patients. Adequate hydration must be maintained.
- Potassium supplements or potassium-rich diets: Because ACE inhibitors reduce aldosterone (which promotes potassium excretion), adding exogenous potassium can push levels dangerously high. Do not supplement potassium without veterinary direction.
Contraindications: Benazepril should not be used in dogs with known hypersensitivity to ACE inhibitors, in pregnant dogs (teratogenic effects documented in other species), or in dogs with bilateral renal artery stenosis (a rare condition). Use with extreme caution in dogs with severe hypotension or hypovolemia.
Practical Takeaways for Dog Owners
What This Means for Your Daily Life
- Consistency is critical. Give benazepril at the same time(s) every day. Missing doses allows RAAS reactivation. Set a phone alarm if needed.
- Do not crush or split extended-release formulations unless your veterinarian specifically instructs you to. Standard Fortekor® tablets can be split along the score line.
- Ensure your dog stays hydrated. ACE inhibitors and diuretics together increase dehydration risk. Always provide fresh water and monitor intake.
- Keep all recheck appointments. Bloodwork is not optional — it is how your veterinarian ensures the medication is helping rather than harming. Budget $150-$300 per recheck, typically every 3-6 months.
- Know the cost. Generic benazepril typically costs $10-$30 per month. Brand-name Fortekor® may cost $30-$60 per month. Compounded formulations (flavored chews, oral suspension) are available from compounding pharmacies for dogs that refuse tablets, typically $25-$50 per month.
- Store properly. Keep tablets at room temperature (68-77°F / 20-25°C) in their original container, away from moisture. Compounded liquids may require refrigeration — follow your pharmacy's instructions.
Frequently Asked Questions
How long does it take for benazepril to work in dogs?
Hemodynamic effects (blood pressure reduction, vasodilation) begin within 1-2 hours of the first dose. However, clinical improvement — reduced coughing in CHF, slowed CKD progression — typically takes 2-4 weeks to become apparent. For CKD patients, the benefit is measured in months and years (slowed progression) rather than immediate symptom relief. Your veterinarian will assess response at the 2-week recheck and adjust dosing as needed.
Can I give benazepril to my dog with food?
Yes. Benazepril can be given with or without food. If your dog experiences stomach upset, giving it with a small meal often helps. Food does not significantly affect absorption. Fortekor® flavored tablets are designed to be palatable and many dogs accept them as treats.
What happens if I miss a dose of benazepril?
Give the missed dose as soon as you remember, unless it is close to the next scheduled dose. If it is nearly time for the next dose, skip the missed one and resume the regular schedule. Never double-dose. A single missed dose is unlikely to cause harm, but frequent missed doses reduce the medication's protective effects and allow RAAS reactivation.
Is benazepril safe for long-term use in dogs?
Yes — in fact, benazepril's benefits are primarily realized through long-term use. Many dogs remain on ACE inhibitors for years. The key to safety is regular monitoring (bloodwork every 3-6 months) so your veterinarian can catch any adverse trends in kidney values or electrolytes early and adjust the dose accordingly.
Can benazepril be used alongside pimobendan and furosemide?
Yes — this three-drug combination (ACE inhibitor + positive inotrope + loop diuretic) is the standard-of-care protocol for canine congestive heart failure and is prescribed together routinely. Spironolactone is often added as a fourth agent. Your veterinarian or veterinary cardiologist will manage the interactions and monitoring.
How is benazepril different from how ACE inhibitors work in humans?
The mechanism is identical — the RAAS is highly conserved across mammals. The differences are pharmacokinetic (dogs metabolize and excrete drugs at different rates), clinical (dogs more commonly present with DMVD rather than the coronary artery disease and essential hypertension that dominate human cardiology), and practical (dogs cannot report symptoms like dizziness, so monitoring relies more heavily on bloodwork and objective measurements). Human ACE inhibitors and veterinary ACE inhibitors target the same enzyme with the same molecular precision.
References and Further Reading
- Merck Veterinary Manual — ACE Inhibitors in Animals
- American Veterinary Medical Association (AVMA) — Animal Health Resources
- FDA Green Book — Approved Animal Drug Products
- Ames, M.K., et al. "The renin-angiotensin-aldosterone system and its suppression." Journal of Veterinary Internal Medicine, 2019.
- Bussadori, C., et al. "The BENRIC study: benazepril in chronic renal insufficiency in cats" — with analogous canine pharmacokinetic data from concurrent investigations.
This article is for informational purposes only and does not replace professional veterinary advice. Always consult your veterinarian before starting, adjusting, or discontinuing any medication for your dog. Individual patient needs vary based on concurrent conditions, body weight, and overall health status.
Tom Renshaw
All our authors care for dogs every day — read more of their work on the authors page.
